Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer.

MLA

Dong, Xuhui, et al. “Efficacy Evaluation of Chimeric Antigen Receptor-Modified Human Peritoneal Macrophages in the Treatment of Gastric Cancer.” British Journal of Cancer, vol. 129, no. 3, Aug. 2023, pp. 551–62. EBSCOhost, https://doi.org/10.1038/s41416-023-02319-6.

APA

Dong, X., Fan, J., Xie, W., Wu, X., Wei, J., He, Z., Wang, W., Wang, X., Shen, P., & Bei, Y. (2023). Efficacy evaluation of chimeric antigen receptor-modified human peritoneal macrophages in the treatment of gastric cancer. British Journal of Cancer, 129(3), 551–562. https://doi.org/10.1038/s41416-023-02319-6

Chicago

Dong, Xuhui, Jiqiang Fan, Wangxu Xie, Xiang Wu, Jia Wei, Zhonglei He, Wenxin Wang, Xueting Wang, Pingping Shen, and Yuncheng Bei. 2023. “Efficacy Evaluation of Chimeric Antigen Receptor-Modified Human Peritoneal Macrophages in the Treatment of Gastric Cancer.” British Journal of Cancer 129 (3): 551–62. doi:10.1038/s41416-023-02319-6.